GC1008 Uses, Dosage, Side Effects and more
GC1008 has been used in trials studying the treatment of Primary Brain Tumors, Metastatic Breast Cancer, Diffuse Systemic Sclerosis, Pleural Malignant Mesothelioma, and Primary Focal Segmental Glomerulosclerosis.
Trade Name | GC1008 |
Generic | Fresolimumab |
Fresolimumab Other Names | Fresolimumab, GC1008 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |